Short Interest in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) Drops By 97.2%

Posted by Stanley Muller on Jul 24th, 2026

M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Get Free Report) saw a significant decline in short interest in the month of July. As of July 15th, there was short interest totaling 8,994 shares, a decline of 97.2% from the June 30th total of 316,916 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 186,077 shares, the days-to-cover ratio is presently 0.0 days.

Institutional Investors Weigh In On M3-Brigade Acquisition V

Several large investors have recently added to or reduced their stakes in MBAV. BCK Capital Management LP increased its position in shares of M3-Brigade Acquisition V by 142.8% during the fourth quarter. BCK Capital Management LP now owns 388,000 shares of the company’s stock worth $4,124,000 after acquiring an additional 228,182 shares during the period. DLD Asset Management LP purchased a new stake in shares of M3-Brigade Acquisition V in the first quarter valued at approximately $644,000. Clear Street Group Inc. grew its stake in M3-Brigade Acquisition V by 26.1% in the fourth quarter. Clear Street Group Inc. now owns 105,000 shares of the company’s stock worth $1,116,000 after purchasing an additional 21,713 shares in the last quarter. FNY Investment Advisers LLC grew its stake in M3-Brigade Acquisition V by 0.8% in the fourth quarter. FNY Investment Advisers LLC now owns 159,700 shares of the company’s stock worth $1,697,000 after purchasing an additional 1,200 shares in the last quarter. Finally, JPMorgan Chase & Co. purchased a new position in M3-Brigade Acquisition V during the 2nd quarter worth $900,000.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of M3-Brigade Acquisition V in a research note on Wednesday, June 24th. Wall Street Zen raised shares of M3-Brigade Acquisition V to a “sell” rating in a research note on Saturday, June 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat, M3-Brigade Acquisition V currently has an average rating of “Sell”.

Read Our Latest Research Report on M3-Brigade Acquisition V

M3-Brigade Acquisition V Stock Performance

MBAV stock traded up $0.15 during midday trading on Friday, reaching $11.29. The company’s stock had a trading volume of 237 shares, compared to its average volume of 161,793. M3-Brigade Acquisition V has a 1 year low of $9.10 and a 1 year high of $11.96. The stock has a fifty day simple moving average of $10.83 and a two-hundred day simple moving average of $10.76.

M3-Brigade Acquisition V (NASDAQ:MBAV – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported $0.05 earnings per share (EPS) for the quarter.

M3-Brigade Acquisition V Company Profile

(Get Free Report)

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.